NVS  Novartis Ag

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

214.5B

Vuru Grade

66.34/100

Current Price

$88.41
-0.72 (-0.81%)

Growth Price

$67.72
Overvalued by 23.40%

Stability Price

$24.64
Overvalued by 72.13%

Company Metrics

  • 22.63 P/E
  • 3.65 P/S
  • 3.07 P/B
  • 3.938 EPS
  • 13.46% Cash ROIC
  • 0.35 Cash Ratio
  • 2.719 / 3.05 % Dividend
  • 1.51M Avg. Vol.
  • 2.43B Shares
  • 214.5B Market Cap.

Company Description

Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide. Its Pharmaceuticals division offers prescription medicines in various therapeutic areas, including cardiovascular and metabolism; oncology; neuroscience and ophthalmics; respiratory; integrated hospital care; and other additional products. The company's Vaccines...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Novartis AG ADR (NVS): New Analyst Report from Zacks Equity Research ...
NASDAQ - Jul 25, 2014
Novartis' second quarter results were disappointing. Core earnings per share came in at $1.34, up 7% from the year-ago period but missed the Zacks Consensus Estimate of $1.36.
Novartis To Offer Stiff Competition To Amgen's Neupogen
Bidness Etc - Jul 25, 2014
Novartis AG (ADR) (NVS) announced yesterday that the Food and Drug Administration (FDA) had accepted the Biologics License Application for filgrastim by Sandoz - the generics arm of Novartis.
Google Inc (GOOGL) and Novartis AG (ADR) (NVS) Join Hands to Develop ...
Tech Insider - Jul 16, 2014
Tech giants are now focusing excessively on wearables that can help users to track health-related issues. According to a report by Bloomberg, Google Inc (NASDAQ:GOOGL) and Novartis AG (ADR) (NYSE:NVS) now have a deal according to which both ...
Google Inc (NASDAQ GOOG) partners with Novartis to develop New Contact Lens - Tech News
Novartis AG (ADR) (NVS) Beats Analyst Estimates; Is Expected To Perform Well ...
Insider Monkey (blog) - Jul 18, 2014
On the deal between Novartis AG (ADR) (NYSE:NVS) and Google Inc. (NASDAQ:GOOGL), Rundquist said that the deal is interesting for both the companies and the deal represents a new way to thinking in healthcare, by combining bio-technology healthcare ...
Novartis Sees Lower-Than-Expected Profits
Bidness Etc - Jul 17, 2014
Novartis AG (NVS) announced its financial and operational results for the second quarter of its 2014 fiscal year (2QFY14) before markets opened today.
Novartis AG (ADR) (NYSE:NVS), Profit Misses Estimates; Forecast Confirmed - Street Register
Novartis AG Misses Earnings Estimates - ValueWalk
Novartis Determined To Counter Alzheimer's Disease
Bidness Etc - Jul 15, 2014
Novartis AG (ADR) (NVS) says it is will partner with the Banner Alzheimer's Institute to conduct a study on preventing Alzheimer's.
Novartis And Google Join Hands To Develop 'Smart' Lens
Bidness Etc - Jul 15, 2014
Novartis AG (NVS) announced today that it has signed a deal with tech giant Google Inc. (GOOG) to develop smart lens technology, for medical purposes specifically pertaining to the eye.
Google, Novartis Partner To Revolutionize Healthcare - ValueWalk
Google Inc (GOOG), Novartis AG To Develop Smart Glucose-Tracking Contact ... - Opptrends
Foreign Companies News: Rio Tinto plc (ADR) (RIO), Novartis AG (ADR) (NVS ...
Insider Monkey (blog) - Jul 17, 2014
Novartis AG (ADR) (NYSE:NVS) posted second-quarter results today, and profits missed analyst estimates. The world's largest drugmaker by sales reported a 2% increase in sales, to $14.6 billion, missing analysts' projections of $14.8 billion, and a 3% ...
Novartis AG (ADR) (NYSE:NVS) Posted Second-Quarter Profit, Hauled By ... - eFinance Hub
Just In: BP plc (ADR) (NYSE:BP), Novartis AG (ADR)(NYSE:NVS) - Market News Call
Biotech Stocks With Unique Diagnostic and Therapeutic Technologies [Novartis ...
ETF Daily News - Jul 24, 2014
For example, Genentech/Roche Holding AG's (RHHBY:OTCQX) Herceptin is almost a $7 billion ($7B) global franchise, but only 20-30% of all breast cancer patients are positive for HER2 (human epidermal growth factor receptor 2), and will respond to the ...
Watch List - Incyte Corporation (INCY), Novartis AG (ADR) (NVS), ACADIA ...
Techsonian (press release) - Jul 12, 2014
Novartis AG (ADR) (NYSE:NVS) deals in patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical ...